Scopio Labs announced the unveiling of its Complete Blood Morphology (CBM) analyzer.
While Complete Blood Counts (CBCs) have been automated for decades, laboratories still require a human in the loop during the Peripheral Blood Smear (PBS) review process. PBS review remains labor intensive, complex, and plagued by inefficiencies and variability resulting in bottlenecks that affect turnaround times, scalability, and ultimately, patient care. These issues are amplified given the ongoing staffing crisis in clinical laboratories. Global workforce shortages, long training cycles, and increased demand for diagnostic tests have left labs struggling to maintain performance.
CBM is built on top of Scopio’s proprietary Full-Field technology, leveraging advanced computational imaging and AI-powered analysis to transform current PBS review workflow into an autonomous, standardized, and clinically relevant process, analyzing 10x more cells than the current standard of care in blood cell morphology.
Scopio will showcase CBM at the ADLM 2025 Annual Conference in Chicago from July 29-31, Booth #3637.
Visit Scopio Labs for more news
